Jordan E. Tuia

发表

Profile of the Oncology Physician Workforce and the Characteristics of Attrition

A. Haslam, V. Prasad, J. Tuia, 2023, JCO oncology practice.

Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed

J. Tuia, Anushka Walia, Vinay Prasad, 2023, Nature Reviews Clinical Oncology.

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials

A. Haslam, Ryan McIntire, Kirstien Minley, 2024, Cancer Medicine.

Systematic review and meta-analysis of randomized trials testing interventions to reduce physician burnout.

A. Haslam, Vinay Prasad, Jordan E. Tuia, 2023, The American journal of medicine.

Eligibility for Human Leukocyte Antigen–Based Therapeutics by Race and Ethnicity

A. Haslam, T. Olivier, Vinay Prasad, 2023, JAMA network open.

Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020

A. Haslam, T. Olivier, V. Prasad, 2022, JAMA internal medicine.

Assessing patient burden and benefit: A decade of cabozantinib clinical trials

A. Haslam, Nicholas B. Sajjadi, Griffin K. Hughes, 2023, International journal of cancer.

The Promise and Pitfalls of Using Crowdsourcing in Research Prioritization for Back Pain: Cross-Sectional Surveys

Anjali R. Truitt, D. Lavallee, D. Patrick, 2017, Journal of medical Internet research.

Cisplatin Shortage Results In Substitution of More Expensive Treatments: Drug Cost Analysis

A. Haslam, T. Olivier, Vinay Prasad, 2024, European Journal of Cancer.